Dendritic cell vaccines in breast cancer: Immune modulation and immunotherapy

The Current Status, Challenges, and Future Potential of Therapeutic Vaccination in Glioblastoma

Personalized dendritic cell vaccination in cancer therapy: An evidence-based research study

A randomised controlled trial of long NY-ESO-1 peptide-pulsed autologous dendritic cells with or without alpha-galactosylceramide in high-risk melanoma

Autologous dendritic cell vaccination against HIV-1 induces changes in natural killer cell phenotype and functionality

Individualized Multimodal Immunotherapy for Adults with IDH1 Wild-Type GBM: A Single Institute Experience

Glioblastoma treatment slowly moves towards change: novel druggable targets and translational horizons in 2022

[Association of autologous tumor lysate-loaded dendritic cell vaccination with extension of survival among patients with newly diagnosed and recurrent glioblastoma]

Modification of Breast Cancer Milieu with Chemotherapy plus Dendritic Cell Vaccine: An Approach to Select Best Therapeutic Strategies

Current „state of the art“ on dendritic cell-based cancer vaccines in melanoma